Additional Information
Market:ASX
Sector:General Mining
EPIC:OVL
Latest Price: 0.11  (0.00%)
52-week High:0.27
52-week Low:0.06
Market Cap:8.65M
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Oro Verde Full Oro Verde profile here

Oro Verde (ASX: OVL), formally Ezenet (ASX: EZE), aims to acquire two prospective copper and gold prospects in Chile.
 
The Chuminga project is in the coastal area of northern Chile which hosts highly prospective copper mines such as Mantos Blancos, Chuquicamata and Escondida. The Vega project is located in Chile's prolific El Indio Gold Belt which has had discoveries in excess of 50 million ounces of gold and 900 million ounces of silver.

Pdf

Oro Verde kicks off gold drilling at Vega, accelerated by good ground conditions

Monday, February 06, 2012 by Angela Kean
Oro Verde kicks off gold drilling at Vega, accelerated by good ground conditions

Oro Verde (ASX: OVL), formerly Ezenet, is rapidly advancing its first phase 8-hole, 2,500 metre drilling program at the Vega Gold Project due to good ground conditions and the vertical nature of the first few holes.

The first two holes have intersected highly altered sulphidic diorite porphyry.

Oro Verde began a reverse circulation drilling program at the Vega Project in the El Indio Gold belt following the completion of drill road access to selected sites to test geochemical anomalies with strong alteration associated with an untested epithermal gold system.

Three holes have been drilled so far with a fourth hole now at 60 metres depth. The first hole in the Sancarron River Valley had to be abandoned prematurely at 11 metres because of high ground water flows.

The second and third holes higher up on the valley side, collared in strong alteration, were terminated at 152 metres and 196 metres respectively.

Both holes have been logged and the individual 1 metre drill intervals are currently being subject to preliminary multi-elemental analysis in the field by a hand held Brunker S1 Turbo XRF before being dispatched to Activation Laboratories in Coquimbo for confirmatory analyses.

The Vega Project comprises 10 gold Exploration Concessions covering 28 kilometres in the El Indio Gold Belt, a region that has seen the discovery of about 50 million ounces of gold and 900 million ounces of silver resources primarily by Barrick Gold Corporation, the dominant miner in the region.

Vega is located 20 kilometres north of El Indio, which produced 4.5 million ounces of gold, 25 million ounces of silver and 472,000 tonnes of copper from underground and open pit operations in its 23 year life.


Chuminga Copper-Gold Project

Drilling operations at Chuminga have been slow due to various mechanical problems, but these matters have been remedied and drilling is progressing.

The first and current core hole at Chuminga is drilling ahead in well-developed copper and iron oxide mineralisation in a gabbro-diorite breccia as predicted. To date some 50 metres of mineralisation has been intersected.

Executive chairman Wolf Martinick said the intersection of well-developed copper and iron oxide mineralisation at Chuminga in a gabbro-diorite breccia as predicted is encouraging.

“We expect the first phase drilling program to confirm the potential of the mineralisation at Chuminga and to provide an exploration data base to proceed to develop a significant JORC compliant copper-gold resource,” he said.


Successful Transition


Oro Verde began trading on the ASX at 10am last Friday after a successful transition to a gold and copper focused explorer in Chile.

The company is currently trading near to its entry price of A$0.20 share, with the last traded price $0.18. 

Oro Verde has some highly prospective bulk tonnage projects, including Chuminga with an exploration target of 50 to 60 million tonnes of between 1% and 1.1% copper, 0.3 to 0.4 grams per tonne gold and 0.5 to 1% zinc, suitable for bulk mining.

The company recently raised around A$2.4 million to assist in the development of its Chilean projects.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.